The antiparkinsonian actions of L-DOPA are attenuated by antagonism of α1-adrenoceptors in MPTP-lesioned macaques

被引：0
|
作者：
Visanji, N. P.
Fox, S. H.
Johnston, T. H.
Millan, M. J.
Brotchie, J. M.
机构：
来源：
MOVEMENT DISORDERS | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1122
引用
收藏
页码：S639 / S639
页数：1
相关论文
共 50 条
  • [21] Evolution of the "short duration" response to L-DOPA in the MPTP-lesioned non-human primate model of Parkinson's disease
    Mestre, T. A.
    Johnston, T. H.
    Brotchie, J. M.
    Fox, S. H.
    MOVEMENT DISORDERS, 2010, 25 (07) : S417 - S417
  • [22] Prior treatment with PYM50028, an orally active neurotrophic factor modulator in development for Parkinson's disease, reduces L-Dopa induced dyskinesia in MPTP-lesioned macaques
    Johnston, T. H.
    Fox, S. H.
    Howson, P. A.
    Brotchie, J. M.
    MOVEMENT DISORDERS, 2011, 26 : S281 - S282
  • [23] Endocannabinoid levels are altered in parkinsonism and L-DOPA-induced dyskinesia in the MPTP-lesioned macaque
    Van der Stelt, M
    Fox, SH
    Di Marzo, V
    Brotchie, JM
    MOVEMENT DISORDERS, 2004, 19 : S397 - S397
  • [24] The α2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of parkinson's disease
    Henry, B
    Fox, SH
    Peggs, D
    Crossman, AR
    Brotchie, JM
    MOVEMENT DISORDERS, 1999, 14 (05) : 744 - 753
  • [25] Gynostemma pentaphyllum Ethanolic Extract Protects Against Memory Deficits in an MPTP-Lesioned Mouse Model of Parkinson's Disease Treated with L-DOPA
    Kim, Kyung Sook
    Zhao, Ting Ting
    Shin, Keon Sung
    Park, Hyun Jin
    Cho, Yoon Jeong
    Lee, Kyung Eun
    Kim, Seung Hwan
    Lee, Myung Koo
    JOURNAL OF MEDICINAL FOOD, 2017, 20 (01) : 11 - 18
  • [26] ANTIPARKINSONIAN ACTIVITY OF TALIPEXOLE IN MPTP-TREATED MONKEYS - IN COMBINATION WITH L-DOPA AND AS CHRONIC TREATMENT
    IRIFUNE, M
    NOMOTO, M
    FUKUDA, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 264 (02) : 117 - 123
  • [27] The effects of central dopa decarboxylase inhibition on the motor actions of A86929 and quinpirole administered in combination to MPTP-lesioned marmosets
    Treseder, SA
    Jackson, M
    Rose, S
    Jenner, P
    Marsden, CD
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 : U37 - U37
  • [28] An α-substituted MDMA ("ecstasy") analogue, ATK-0101, extends the duration of L-DOPA action in the MPTP-lesioned primate model of Parkinson's disease
    Johnston, T. H.
    Fox, S. H.
    McIldowie, M. J.
    Piggott, M. J.
    Brotchie, J. M.
    MOVEMENT DISORDERS, 2006, 21 : S642 - S642
  • [29] Effect of the mGlu2 positive allosteric modulator biphenyl-indanone A as a monotherapy and as adjunct to a low dose of L-DOPA in the MPTP-lesioned marmoset
    Kang, Woojin
    Frouni, Imane
    Kwan, Cynthia
    Bedard, Dominique
    Nuara, Stephen G.
    Hamadjida, Adjia
    Gourdon, Jim C.
    Huot, Philippe
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2024, 60 (09) : 6175 - 6184
  • [30] NMDA ANTAGONISTS POTENTIATE ANTIPARKINSONIAN ACTIONS OF L-DOPA IN MONOAMINE-DEPLETED RATS
    KLOCKGETHER, T
    TURSKI, L
    ANNALS OF NEUROLOGY, 1990, 28 (04) : 539 - 546
12345